MedPath

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention

Phase 1
Completed
Conditions
Coxarthritis
Registration Number
NCT02970253
Lead Sponsor
ZOL
Brief Summary

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular resection versus capsular flap retention.

Prospective study design comparing clinical data in randomized THA patients who either had capsular resection or capsular flap retention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
190
Inclusion Criteria
  • primary THA
Exclusion Criteria
  • neurologic disease
  • painful contralateral THA
  • severe back or knee pain
  • rheumatology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinical data will be measured with scoring list HHS (Harris Hip Score).One year

Hypothesis: No clinical difference in DAA using capsular resection vs retention. Clinical outcomes will be measured with scoring list HHS (Harris Hip Score).

Clinical data will be measured with scoring list WOMAC (The Western Ontario and McMaster Universities Arthritis Index).One year

Hypothesis: No clinical difference in DAA using capsular resection vs retention. Clinical outcomes will be measured with scoring list WOMAC (The Western Ontario and McMaster Universities Arthritis Index).

Clinical data will be measured with scoring list UCLA (University of California Los Angles activity score).One year

Hypothesis: No clinical difference in DAA using capsular resection vs retention. Clinical outcomes will be measured with scoring list UCLA ((University of California Los Angles activity score).

Clinical data will be measured with scoring list HOOS (Hip dysfunction and Osteoarthritis Outcome Score).One year

Hypothesis: No clinical difference in DAA using capsular resection vs retention. Clinical outcomes will be measured with scoring lists HOOS (Hip dysfunction and Osteoarthritis Outcome Score).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ZOL

🇧🇪

Genk, Limburg, Belgium

ZOL
🇧🇪Genk, Limburg, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.